by HealthDay Reporter | Feb 8, 2024
The U.S. Food and Drug Administration has approved Dupixent (dupilumab) for the treatment of pediatric patients (aged 1 to 11 years) with eosinophilic esophagitis (EoE). MONDAY, Jan. 29, 2024 (HealthDay News) — The U.S. Food and Drug Administration...by HealthDay Reporter | Jan 31, 2024
Incremental cost-effectiveness ratios were $126,000 and $281,000 per QALY for two simulation models from a societal perspective. MONDAY, Jan. 22, 2024 (HealthDay News) — Gene therapy for sickle cell disease (SCD) below $2 million is likely to be...by HealthDay Reporter | Jan 25, 2024
Casgevy is the first CRISPR-based medicine to be approved for use in the United States. Adobe Stock WEDNESDAY, Jan. 17, 2024 (HealthDay News) — After approving Casgevy (exagamglogene autotemcel) in December to treat sickle cell disease, the U.S....Cookie | Duration | Description |
---|---|---|
cookielawinfo-checkbox-analytics | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics". |
cookielawinfo-checkbox-functional | 11 months | The cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional". |
cookielawinfo-checkbox-necessary | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary". |
cookielawinfo-checkbox-others | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other. |
cookielawinfo-checkbox-performance | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance". |
viewed_cookie_policy | 11 months | The cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data. |